o2h Ventures
EIS and SEIS funds backing UK biotech, drug discovery and life-science companies
- Venture capital
- Cambridge
- Type
- Venture capital
- Based in
- Cambridge
- Stages
- Pre-seed, Seed, Series A, Series B+
- Sector focus
- Healthtech
- Cheque size
- €100k–€1.5M
- Fund size
- £10m
- Website
- o2hventures.com
A Cambridge-based investor running EIS and SEIS-compliant funds that back UK biotech companies working on therapeutics, drug discovery platforms and other life-science technologies, including AI for drug discovery, oncology, neuroscience, genomics, anti-infectives and biologics.
Its fund targets £10m and builds portfolios of five to ten unquoted or AIM-listed companies, with exits expected over three to seven years; investors can commit from £25,000. The team operates from the Mill SciTech Park in Hauxton, a 2.7-acre site where it also incubates life-science companies. It was founded by Sunil Shah and Prashant Shah.
← All investors · Is this your organisation? Request an update
More investors in the directory
The Craftory
Purpose-driven consumer packaged goods brands with category-changing potential
Symvan Capital
EIS and SEIS funds backing B2B SaaS and technology companies from seed to exit
Grafton Capital
Growth capital for European software, AI and tech-enabled businesses
Blackfinch Ventures
EIS and VCT investment in early and growth-stage UK technology businesses
The Conduit Connect
Impact-led UK startups from pre-seed to Series A in climate, health and financial resilience
TrueSight Ventures
Angel-sized cheques at pre-seed and seed, sector-agnostic, into technology companies
Subscribe to Newsletter
Join me on this exciting journey as we explore the boundless world of web design together.